MedPath

An intervention study for bronchiolitis in Darwin and Townsville - Comparing severity of disease and readmission of infants given azithromycin or placebo.

Phase 4
Completed
Conditions
Bronchiolitis
Respiratory - Other respiratory disorders / diseases
Registration Number
ACTRN12608000150347
Lead Sponsor
Royal Darwin Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
97
Inclusion Criteria

18 months of age and less Diagnosis of Bronchiolitis (defined as cough/coryza, wheezing +/- crackles, tachypnoea, retraction) requiring supplemented oxygen informed consent from parent/primary care giver

Exclusion Criteria

Contraindication to macrolide therapy,
chronic lung disease, currently on azithromycin therapy,
complex congenital heart disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath